Author

B. Berkeveld

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. J. Kuipers· 1 shared A. Li· 1 shared A. Thom· 1 shared B. Boers· 1 shared B. Kazemier· 1 shared B. N. Duplantis· 1 shared B. S. de Vries· 1 shared E. van Geffen· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. J. Kuipers

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cornering an Ever-Evolving Coronavirus: TATX-03, a fully human synergistic multi-antibody cocktail targeting the SARS-CoV-2 Spike Protein with in vivo efficacy

I. Roodink, M. van Erp, A. Li, S. Potter, S. M. J. van Duijnhoven, A. J. Kuipers, B. Kazemier, E. van Geffen, W. Hemrika, B. Berkeveld, G. Sonnemans, B. S. de Vries, B. Boers, M. Smits, S. Meurs, , Y. N. Abdiche

This paper describes the development of a multi-antibody cocktail (TATX-03) that effectively neutralizes SARS-CoV-2 in vivo and maintains potency against variants of concern.

bioRxiv · Jul 20, 2021 · PreprintImmunology